There's a well-documented gap between the hormonal health care women need and what traditional primary care delivers. It's not a matter of individual physicians not caring; it's that the 15-minute appointment structure makes thorough hormonal evaluation nearly impossible.
Consider what perimenopausal or thyroid evaluation actually requires: a detailed symptom history, nuanced interpretation of labs in clinical context, a discussion of treatment options (bioidentical hormones versus conventional HRT versus lifestyle versus thyroid optimization), ongoing monitoring, and adjustment based on response. That's a 45-minute conversation at minimum, and it needs to happen repeatedly as symptoms evolve.
In a concierge practice, that conversation actually happens. Here's how I approach women's hormonal health and what the current evidence supports.
The common gaps
The hormonal transitions affecting women (perimenopause, menopause, thyroid dysfunction, PCOS, adrenal dysregulation) share certain features: complex, individualized, evolving over time. They require longitudinal attention rather than single-visit management.
Perimenopause and menopause
Perimenopause can begin up to 10 years before the last menstrual period, often in the early to mid 40s. Symptoms are notoriously variable: irregular periods, sleep disruption, mood changes, brain fog, joint pain, reduced libido, vaginal dryness, weight gain, and more. Many women spend years having these symptoms attributed to anxiety, depression, or stress before anyone considers the hormonal picture.
The 2002 Women's Health Initiative study created a generation of physicians overcautious about menopausal hormone therapy (MHT). Subsequent data and updated guidelines from NAMS, the Endocrine Society, and ACOG have substantially revised that picture. For most healthy women under 60 who are within 10 years of menopause onset, MHT has a favorable benefit-to-risk profile. Navigating this decision requires a physician who's read the updated literature and has time to discuss it.
Thyroid disorders
Thyroid dysfunction affects women at roughly 5 to 8 times the rate of men. Hypothyroidism specifically is under-diagnosed. A standard TSH screening misses many patients with subclinical or functional thyroid issues who nonetheless have significant symptoms.
A thorough thyroid workup includes full panels (TSH, free T4, free T3, reverse T3, thyroid antibodies including TPO and thyroglobulin antibodies), clinical correlation with symptoms, and willingness to treat based on the complete picture rather than a single number.
PCOS and related metabolic disorders
Polycystic ovary syndrome affects approximately 1 in 10 women of reproductive age and is one of the most common endocrine disorders in medicine. Management involves insulin resistance, androgen excess, menstrual irregularity, and fertility concerns. It requires coordinated, ongoing attention that traditional primary care rarely provides.
How I approach women's hormonal health
The evaluation needs to actually be comprehensive:
Baseline testing. Full hormone panel including sex hormones (estradiol, progesterone, testosterone, SHBG, DHEA-S, FSH/LH where relevant), thyroid panel as above, adrenal markers (cortisol timing, DHEA-S), metabolic markers (fasting insulin, A1C), lipid panel with particle analysis, vitamin D, and inflammatory markers. Not just TSH and estradiol.
Symptom-correlated interpretation. Lab values get interpreted in the context of your symptoms, history, and life stage. Population reference ranges don't always apply to the individual patient, particularly in perimenopause.
Time for the conversation. The initial hormonal consultation takes a full visit, typically 60 to 90 minutes, to understand the complete picture. Follow-ups allow time to discuss what's changing, what's working, and what needs adjustment.
Personalized treatment planning. The right approach might be lifestyle modification, bioidentical hormone therapy, conventional HRT, thyroid optimization, or some combination. The plan gets tailored to your values, preferences, and clinical picture.
Longitudinal monitoring. Hormonal transitions don't resolve in one visit. Symptoms evolve, doses need adjusting, new developments arise. A concierge relationship accommodates this rhythm.
The menopause hormone therapy question
Given the history of HRT controversy, many women arrive uncertain whether hormone therapy is appropriate for them. The current evidence supports MHT for most women experiencing significant menopausal symptoms who are:
- Within 10 years of menopause onset (or under 60 years old)
- Without specific contraindications: personal history of breast cancer, active cardiovascular disease, history of certain clotting disorders, unexplained vaginal bleeding
The conversation about whether, when, and how to use hormone therapy depends on your symptom burden, personal history, family history, and preferences. It's a real conversation, not a 15-minute decision.
Options include estradiol patches, oral estradiol, topical formulations, compounded bioidentical hormones, combination therapies with progesterone for women with intact uterus, and newer options like non-hormonal treatments (fezolinetant) for patients who can't or won't use hormones. Each has tradeoffs.
Women's health beyond hormones
A thoughtful approach to women's health in midlife also covers:
Bone health. Appropriate osteoporosis risk assessment, DEXA scanning at the right intervals, calcium and vitamin D optimization, fracture prevention strategies.
Cardiovascular risk. Women's cardiovascular risk differs from men's in meaningful ways and is often under-recognized. Presenting symptoms are different, risk factor weights differ, and some women's cardiac events get missed because the presentation doesn't match the classic male pattern. Cardiovascular risk assessment should be specific rather than generic.
Mental health. Hormonal fluctuations meaningfully affect mood and cognition. Depression, anxiety, and cognitive symptoms that emerge during perimenopause deserve hormonal evaluation as part of the workup, not just psychiatric treatment in isolation.
Sleep. Poor sleep during menopause isn't just a quality-of-life issue. It has cardiovascular, metabolic, and cognitive consequences. Addressing sleep is part of the hormonal picture.
Why this matters long-term
The consequences of under-treated hormonal issues aren't just symptomatic. Long-term estrogen deficiency is associated with accelerated cardiovascular disease, osteoporosis, cognitive decline, and genitourinary dysfunction. Untreated hypothyroidism increases cardiovascular and metabolic risk. These aren't cosmetic concerns.
Good hormonal care in midlife is preventive medicine. Getting it right in your 40s and 50s pays dividends for the following three decades.
If you want to talk
If you've felt dismissed, rushed, or inadequately addressed in your hormonal health care, or if symptoms are being attributed to anxiety when you suspect something hormonal is happening, a concierge practice may be a better fit. Reach out if you want to talk through the specifics.
For more on concierge medicine generally, see is concierge medicine worth it and how to choose a concierge doctor.
